These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6105685)

  • 21. Structure-activity relationships in 1,4-benzodioxan-related compounds. 2. Role of the amine function on alpha-adrenoreceptor blocking activity.
    Giardinà D; Gulini U; Pigini M; Piloni MG; Melchiorre C
    Farmaco; 1990 Dec; 45(12):1289-98. PubMed ID: 1982488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.
    Colabufo NA; Pagliarulo V; Berardi F; Contino M; Perrone R; Niso M; Albo G; de Rienzo G; Pagliarulo A
    Eur J Pharmacol; 2007 Dec; 577(1-3):150-5. PubMed ID: 17900563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.
    Olsson OA; Ahlquist B; Gustafsson B
    Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A kinetic analysis of the alpha 1-adrenergic reaction of the smooth muscles in the rat vas deferens].
    Manukhin BN; Berdysheva LV; Khakimova DKh
    Fiziol Zh SSSR Im I M Sechenova; 1990 Jul; 76(7):863-8. PubMed ID: 2174379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
    Bierer DE; Fort DM; Mendez CD; Luo J; Imbach PA; Dubenko LG; Jolad SD; Gerber RE; Litvak J; Lu Q; Zhang P; Reed MJ; Waldeck N; Bruening RC; Noamesi BK; Hector RF; Carlson TJ; King SR
    J Med Chem; 1998 Mar; 41(6):894-901. PubMed ID: 9526563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic effects of oxypertine on the isolated vas deferens of the rat.
    Miranda H; Naquira D
    Gen Pharmacol; 1978; 9(5):325-8. PubMed ID: 29822
    [No Abstract]   [Full Text] [Related]  

  • 27. New 2-substituted 2,3,3a,4-tetrahydro-1H-imidazo[5,1-c] [1,4]benzoxazin-1-ones as alpha 2-adrenoceptor antagonists.
    Melloni P; Banzatti C; Heidempergher F; Marazzi G; Ricciardi S; Vaghi F; Varasi M
    Farmaco; 1991 Sep; 46(9):1011-21. PubMed ID: 1687241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to adrenergic alpha-blocking agents by twitch-like contraction following field stimulation in rabbit vas deferens.
    Nakanishi H; Enatsu C; Watanabe T
    Fukushima J Med Sci; 1977; 24(3-4):107-15. PubMed ID: 33111
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of subchronic exposure of rats to lead or zinc on alpha-adrenoceptor-mediated contractile responses in isolated vas deferens.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D; Lasova L; Radomirov R
    Acta Physiol Pharmacol Bulg; 1993; 19(4):111-9. PubMed ID: 8203281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dualism in the alpha-adrenoceptor blocking action of dihydroergocristine.
    Lucchelli A; Zonta F; Grana E; Turba C; Pagella P
    Pharmacol Res Commun; 1981 Mar; 13(3):231-40. PubMed ID: 6111090
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenergic effects of (-) quebrachamin.
    Ganguly DK; Chaudhuri SK; Bhattacharya BB; Bhattacharya R; Saha L
    Indian J Med Res; 1972 Apr; 60(4):594-8. PubMed ID: 4660290
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific alpha-adrenoceptor blocking effect of droperidol on isolated smooth muscles.
    van Nueten JM; Reneman RS; Janssen PA
    Eur J Pharmacol; 1977 Jul; 44(1):1-8. PubMed ID: 18356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cryptolepine alone and in combination with dipyridamole on a mouse model of arterial thrombosis.
    Oyekan AO; Okafor JP
    J Ethnopharmacol; 1989 Nov; 27(1-2):141-8. PubMed ID: 2575690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodination and preliminary in vivo investigation of the alkaloid cryptolepine.
    Salako Q; Ablordeppey SY; Dwuma-Badu D; Thornback JR
    Int J Appl Radiat Isot; 1985 Dec; 36(12):1003-4. PubMed ID: 2867977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo.
    Oyekan AO; Botting JH; Noamesi BK
    Gen Pharmacol; 1988; 19(2):233-7. PubMed ID: 2895035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonists.
    Caroon JM; Clark RD; Kluge AF; Olah R; Repke DB; Unger SH; Michel AD; Whiting RL
    J Med Chem; 1982 Jun; 25(6):666-70. PubMed ID: 6124635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism(s) of the antiaggregatory effects of cryptolepine: the role of cyclic adenosine monophosphate and cellular Ca2+.
    Oyekan AO; Ablordeppey SY
    Gen Pharmacol; 1993 Mar; 24(2):461-9. PubMed ID: 7683302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source.
    Deutsch HF; Evenson MA; Drescher P; Sparwasser C; Madsen PO
    J Pharm Biomed Anal; 1994 Oct; 12(10):1283-7. PubMed ID: 7841224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological effects of Synclisia scabrida alkaloid B on some isolated muscle preparations.
    Wambebe C; Bodhankar S; Ogbeide ON; Okor DI
    J Ethnopharmacol; 1982 Nov; 6(3):255-61. PubMed ID: 7154694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the type of antiserotoninergic antagonism exerted in vitro on rat's stomach by pineal indole derivatives].
    Fioretti MC; Menconi E; Riccardi C
    Farmaco Prat; 1974 Jul; 29(7):401-12. PubMed ID: 4858640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.